Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazushi Inoue

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Cancer Investigation|November 7, 2018
Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN NetworkKazushi Inoue, Elizabeth A Fry
Cancer Reports and Reviews|June 29, 2018
Aberrant expression of p16<sup>INK4a</sup> in human cancers - a new biomarker?Kazushi Inoue, Elizabeth A Fry
Advances in Medicine and Biology|July 7, 2017
Haploinsufficient tumor suppressor genesKazushi Inoue, Elizabeth A Fry
Signal Transduction Insights|January 17, 2017
Aberrant expression of cyclin D1 in cancerKazushi Inoue, Elizabeth A Fry
Cancer Reports and Reviews|July 6, 2018
Aberrant expression of ETS1 and ETS2 proteins in cancerElizabeth A Fry, Kazushi Inoue
Sub-Cellular Biochemistry|September 10, 2014
Alterations of p63 and p73 in human cancersKazushi Inoue, Elizabeth A Fry
Genetics & Epigenetics|December 23, 2015
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerKazushi Inoue, Elizabeth A Fry
International Journal of Cancer|January 24, 2016
Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancerKazushi Inoue, Elizabeth A Fry
Tumor & Microenvironment|February 12, 2019
Aberrant Expression of p14<sup>ARF</sup> in Human Cancers: A New Biomarker?Kazushi Inoue, Elizabeth A Fry
Cancer Investigation|January 3, 2019
c-MYB and DMTF1 in CancerElizabeth A Fry, Kazushi Inoue
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Cancer Investigation|November 7, 2018
Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN NetworkKazushi Inoue, Elizabeth A Fry
Cancer Reports and Reviews|June 29, 2018
Aberrant expression of p16<sup>INK4a</sup> in human cancers - a new biomarker?Kazushi Inoue, Elizabeth A Fry
Advances in Medicine and Biology|July 7, 2017
Haploinsufficient tumor suppressor genesKazushi Inoue, Elizabeth A Fry
Signal Transduction Insights|January 17, 2017
Aberrant expression of cyclin D1 in cancerKazushi Inoue, Elizabeth A Fry
Cancer Reports and Reviews|July 6, 2018
Aberrant expression of ETS1 and ETS2 proteins in cancerElizabeth A Fry, Kazushi Inoue
Sub-Cellular Biochemistry|September 10, 2014
Alterations of p63 and p73 in human cancersKazushi Inoue, Elizabeth A Fry
Genetics & Epigenetics|December 23, 2015
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerKazushi Inoue, Elizabeth A Fry
International Journal of Cancer|January 24, 2016
Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancerKazushi Inoue, Elizabeth A Fry
Tumor & Microenvironment|February 12, 2019
Aberrant Expression of p14<sup>ARF</sup> in Human Cancers: A New Biomarker?Kazushi Inoue, Elizabeth A Fry
Cancer Investigation|January 3, 2019
c-MYB and DMTF1 in CancerElizabeth A Fry, Kazushi Inoue
Pageof 4